Following approval in the UK in 2017, Humedics has now also received Marketing Authorization for its diagnostic agent, LiMAxetin®, in Germany and Austria.
After five years of follow-up observation, CO.DON AG has brought the Phase II clinical trial “co.dis” to a successful close. In the long-term clinical study 75 patients aged between 18 and 50, with cartilage defects in the knee, were treated with the…
From April 1, 2018 Professor Roland Eils takes up the professorship for Digital Health at the Berlin Institute of Health (BIH) and the Charité – Universitätsmedizin Berlin. Professor Eils will therefore take responsibility for one of the central…
Background
Sensors with the features: portable, low-power, label-free, real-time, compact, high sensitivity, high-throughput, and cost-effective are highly attractive because they can be used in a wide range of fields such as environmental…
Hose pinch valves are closed by the compression of a flexible section of the valve or by a segment of a tube shifting a compression body against the tube or impinging the compression section with an actuator. In both cases the tube has to be placed…
Challenge
A quick and reliable method for non-invasive measuring of pressures and pressure gradients in the aorta is of importance for a variety of clinical use cases. For example, in coarctation of the aorta clinical guidelines recommend to commence…
Four Berlin institutions, the Freie Universität Berlin, Humboldt-Universität zu Berlin, Technische Universität Berlin, the Charité – Universitätsmedizin Berlin, and the University of Oxford, have set out to create a new partnership which will open up…
TissUse and Roche have signed a cooperating agreement to develop human-relevant in vitro assays based on TissUse’s Multi-Organ-Chip technology.
Berlin is the new startup hub in Europe
New ERC-funded project at Charité to combine EEG data and machine learning
